PC

Puxin Capital

Asia, Shanghai, China, Shanghai

Description

Puxin Capital is an investment firm that targets Chinese private equity opportunities.

Investor Profile

Puxin Capital has backed more than 4 startups, with 2 new investments in the last 12 months alone. The firm has led 1 rounds, about 25% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A, Series Unknown, Series B rounds (top funding stages).
  • Majority of deals are located in China, Switzerland.
  • Strong thematic focus on Artificial Intelligence (AI), Asset Management, Big Data.
  • Led 1 rounds in the past year.

Stage Focus

  • Series A (50%)
  • Series Unknown (25%)
  • Series B (25%)

Country Focus

  • China (75%)
  • Switzerland (25%)

Industry Focus

  • Artificial Intelligence (Ai)
  • Asset Management
  • Big Data
  • Risk Management
  • Software
  • Digital Signage
  • Infrastructure
  • Biotechnology
  • Genetics
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Puxin Capital frequently co-invest with?

Singtel Innov8
Asia, Central Region, Singapore, Singapore
Co-Investments: 1
Goldman Sachs
North America, New York, United States, New York
Co-Investments: 1
Hua Di Investment
Asia, Guangdong, China, Guangzhou
Co-Investments: 1
QF
Asia, Guangdong, China, Shenzhen
Co-Investments: 1
Mount Morning Capital
Asia, Beijing, China, Beijing
Co-Investments: 1
Empower Investment
Asia, Shanghai, China, Shanghai
Co-Investments: 1
SilkRoad GoldenBridge Capital
Asia, Guangdong, China, Futian
Co-Investments: 1
Shenzhen Angel FOF
Asia, Guangdong, China, Shenzhen
Co-Investments: 1
Intel Capital
North America, California, United States, Santa Clara
Co-Investments: 1
Guangdong Yuecai Venture Capital Co., Ltd.
Asia, Guangdong, China, Guangzhou
Co-Investments: 1

What are some of recent deals done by Puxin Capital?

AlpsenTek

Zürich, Zurich, Switzerland

AlpsenTek is a company engaged in the research and development of machine vision sensors and algorithms.

Artificial Intelligence (AI)SemiconductorSensor
Series BApr 16, 2025
Anda Biopharma

Shenzhen, Guangdong, China

Anda Biopharma is an AI-driven tumor neoantigen therapy developer.

Artificial Intelligence (AI)BiotechnologyGeneticsPharmaceutical
Series AMar 24, 2025
AI-LINK

Shenzhen, Guangdong, China

AI-LINK is a digital infrastructure provider focused on industrial sites.

Digital SignageInfrastructure
Series AFeb 1, 2024
Amount Raised: $21,123,785
XunceTech

Shenzhen, Guangdong, China

XunceTech operates a risk management system and data management service provider.

Asset ManagementBig DataRisk ManagementSoftware
Series UnknownMar 1, 2021
Amount Raised: $15,311,330